Skip to main content
Top
Published in: Journal of Inflammation 1/2014

Open Access 01-12-2014 | Research

A cardiopulmonary bypass with deep hypothermic circulatory arrest rat model for the investigation of the systemic inflammation response and induced organ damage

Authors: Melanie Engels, Esra Bilgic, Antonio Pinto, Edwin Vasquez, Lena Wollschläger, Holger Steinbrenner, Kristine Kellermann, Payam Akhyari, Artur Lichtenberg, Udo Boeken

Published in: Journal of Inflammation | Issue 1/2014

Login to get access

Abstract

Background

Cardiopulmonary bypass (CPB) is a commonly used technique in cardiac surgery. CPB is however associated with a strong induction of systemic inflammatory response syndrome (SIRS) which in conjunction with ischemia and reperfusion may lead to multiple organ failure.
The aim of the study was to establish and characterize a CPB rat model incorporating deep hypothermic circulatory arrest with a specific focus on the extent of the inflammatory reactions and organ damage as a groundwork for novel therapeutics against SIRS and I/R induced organ injury.

Materials and methods

Male Wistar rats (n = 6) were cannulated for CPB, connected to a heart-lung-machine (HLM) and cooled to a temperature of 16°C before they underwent 45 minutes of deep hypothermic circulatory arrest with global ischaemia. Arrest was followed by rewarming and 60 minutes of reperfusion. Haemodynamic and vital parameters were recorded throughout the CPB procedure. Only animals displaying sinus rhythm throughout reperfusion were utilized for analysis. Rats were euthanized and tissue samples were harvested. Blood gas analysis was performed and blood samples were taken. Induction of organ damage was examined by analysis of protein levels and phosphorylation status of kinases and stress proteins. Results were compared to animals (n = 6) which did not undergo CPB.

Results

CPB induced leucocytosis and an increase of interleukin-6 and TNF-α plasma values indicating an inflammatory response. Markers of tissue damage and dysfunction, such as troponin T, creatinine and AST were elevated. Phosphorylation of STAT3 was induced in all examined organs. Activation of MAPK and induction of heat shock proteins occurred in an organ-specific manner with most pronounced effects in heart, lungs and kidneys.

Conclusions

The presented CPB rat model shows the induction of SIRS and activation of specific signalling cascades. SIRS seems not to be provoked during DHCA and is elicited mainly during reperfusion. This model might be suitable to test the efficacy of therapeutics applied in major heart surgery with and without DHCA.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD: Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983, 86 (6): 845-857.PubMed Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD: Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983, 86 (6): 845-857.PubMed
2.
go back to reference Kunes P, Lonsky V, Mand'ak J, Brtko M, Kolackova M, Andrys C, Kudlova M, Krejsek J: The inflammatory response in cardiac surgery. An up-to-date overview with the emphasis on the role of heat shock proteins (HSPs) 60 and 70. Acta medica (Hradec Kralove). 2007, 50 (2): 93-99. Kunes P, Lonsky V, Mand'ak J, Brtko M, Kolackova M, Andrys C, Kudlova M, Krejsek J: The inflammatory response in cardiac surgery. An up-to-date overview with the emphasis on the role of heat shock proteins (HSPs) 60 and 70. Acta medica (Hradec Kralove). 2007, 50 (2): 93-99.
3.
go back to reference Boeken U, Feindt P, Zimmermann N, Kalweit G, Petzold T, Gams E: Increased preoperative C-reactive protein (CRP)-values without signs of an infection and complicated course after cardiopulmonary bypass (CPB)-operations. Eur J Cardiothorac Surg. 1998, 13 (5): 541-545. 10.1016/S1010-7940(98)00062-1.PubMedCrossRef Boeken U, Feindt P, Zimmermann N, Kalweit G, Petzold T, Gams E: Increased preoperative C-reactive protein (CRP)-values without signs of an infection and complicated course after cardiopulmonary bypass (CPB)-operations. Eur J Cardiothorac Surg. 1998, 13 (5): 541-545. 10.1016/S1010-7940(98)00062-1.PubMedCrossRef
4.
go back to reference Ni Choileain N, Redmond HP: Cell response to surgery. Arch Surg. 2006, 141 (11): 1132-1140. 10.1001/archsurg.141.11.1132.PubMedCrossRef Ni Choileain N, Redmond HP: Cell response to surgery. Arch Surg. 2006, 141 (11): 1132-1140. 10.1001/archsurg.141.11.1132.PubMedCrossRef
5.
go back to reference Moore FA, Moore EE: Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin North Am. 1995, 75 (2): 257-277.PubMed Moore FA, Moore EE: Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin North Am. 1995, 75 (2): 257-277.PubMed
6.
go back to reference Marik PE, Flemmer M: The immune response to surgery and trauma: Implications for treatment. J Trauma Acute Care Surg. 2012, 73 (4): 801-808. 10.1097/TA.0b013e318265cf87.PubMedCrossRef Marik PE, Flemmer M: The immune response to surgery and trauma: Implications for treatment. J Trauma Acute Care Surg. 2012, 73 (4): 801-808. 10.1097/TA.0b013e318265cf87.PubMedCrossRef
7.
go back to reference Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Miyazaki M: Immunosuppression following surgical and traumatic injury. Surg Today. 2010, 40 (9): 793-808. 10.1007/s00595-010-4323-z.PubMedCrossRef Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Miyazaki M: Immunosuppression following surgical and traumatic injury. Surg Today. 2010, 40 (9): 793-808. 10.1007/s00595-010-4323-z.PubMedCrossRef
8.
go back to reference Christenson JT, Aeberhard JM, Badel P, Pepcak F, Maurice J, Simonet F, Velebit V, Schmuziger M: Adult respiratory distress syndrome after cardiac surgery. Cardiovasc Surg. 1996, 4 (1): 15-21. 10.1016/0967-2109(96)83778-1.PubMedCrossRef Christenson JT, Aeberhard JM, Badel P, Pepcak F, Maurice J, Simonet F, Velebit V, Schmuziger M: Adult respiratory distress syndrome after cardiac surgery. Cardiovasc Surg. 1996, 4 (1): 15-21. 10.1016/0967-2109(96)83778-1.PubMedCrossRef
9.
go back to reference Prasad A, Stone GW, Holmes DR, Gersh B: Reperfusion injury, microvascular dysfunction, and cardioprotection: the “dark side” of reperfusion. Circulation. 2009, 120 (21): 2105-2112. 10.1161/CIRCULATIONAHA.108.814640.PubMedCrossRef Prasad A, Stone GW, Holmes DR, Gersh B: Reperfusion injury, microvascular dysfunction, and cardioprotection: the “dark side” of reperfusion. Circulation. 2009, 120 (21): 2105-2112. 10.1161/CIRCULATIONAHA.108.814640.PubMedCrossRef
10.
go back to reference Sanada S, Komuro I, Kitakaze M: Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures. Am J Physiol-Heart C. 2011, 301 (5): H1723-H1741. 10.1152/ajpheart.00553.2011.CrossRef Sanada S, Komuro I, Kitakaze M: Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures. Am J Physiol-Heart C. 2011, 301 (5): H1723-H1741. 10.1152/ajpheart.00553.2011.CrossRef
11.
go back to reference Maganti M, Badiwala M, Sheikh A, Scully H, Feindel C, David TE, Rao V: Predictors of low cardiac output syndrome after isolated mitral valve surgery. J Thorac Cardiovasc Surg. 2010, 140 (4): 790-796. 10.1016/j.jtcvs.2009.11.022.PubMedCrossRef Maganti M, Badiwala M, Sheikh A, Scully H, Feindel C, David TE, Rao V: Predictors of low cardiac output syndrome after isolated mitral valve surgery. J Thorac Cardiovasc Surg. 2010, 140 (4): 790-796. 10.1016/j.jtcvs.2009.11.022.PubMedCrossRef
12.
go back to reference Hessel EA: Abdominal organ injury after cardiac surgery. Semin Cardiothorac Vasc Anesth. 2004, 8 (3): 243-263. 10.1177/108925320400800306.PubMedCrossRef Hessel EA: Abdominal organ injury after cardiac surgery. Semin Cardiothorac Vasc Anesth. 2004, 8 (3): 243-263. 10.1177/108925320400800306.PubMedCrossRef
13.
go back to reference Jiménez JJ, Iribarren JL, Brouard M, Hernández D, Palmero S, Jiménez A, Lorente L, Machado P, Borreguero JM, Raya JM, Martín B, Pérez R, Martínez R, Mora ML: Safety and effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dose-dependent, phase IV clinical trial. J Cardiothorac Surg. 2011, 6: 138-10.1186/1749-8090-6-138.PubMedPubMedCentralCrossRef Jiménez JJ, Iribarren JL, Brouard M, Hernández D, Palmero S, Jiménez A, Lorente L, Machado P, Borreguero JM, Raya JM, Martín B, Pérez R, Martínez R, Mora ML: Safety and effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dose-dependent, phase IV clinical trial. J Cardiothorac Surg. 2011, 6: 138-10.1186/1749-8090-6-138.PubMedPubMedCentralCrossRef
14.
go back to reference Jungwirth B, Mackensen GB, Blobner M, Neff F, Reichart B, Kochs EF, Nollert G: Neurologic outcome after cardiopulmonary bypass with deep hypothermic circulatory arrest in rats: description of a new model. J Thorac Cardiovasc Surg. 2006, 131 (4): 805-812. 10.1016/j.jtcvs.2005.11.017.PubMedCrossRef Jungwirth B, Mackensen GB, Blobner M, Neff F, Reichart B, Kochs EF, Nollert G: Neurologic outcome after cardiopulmonary bypass with deep hypothermic circulatory arrest in rats: description of a new model. J Thorac Cardiovasc Surg. 2006, 131 (4): 805-812. 10.1016/j.jtcvs.2005.11.017.PubMedCrossRef
15.
go back to reference Lewis FJ, Taufic M: Closure of atrial septal defects with the aid of hypothermia; experimental accomplishments and the report of one successful case. Surgery. 1953, 33 (1): 52-59.PubMed Lewis FJ, Taufic M: Closure of atrial septal defects with the aid of hypothermia; experimental accomplishments and the report of one successful case. Surgery. 1953, 33 (1): 52-59.PubMed
16.
go back to reference Griepp RB, Di Luozzo G: Hypothermia for aortic surgery. J Thorac Cardiovasc Surg. 2013, 145 (3, Supplement): S56-S58. 10.1016/j.jtcvs.2012.11.072.PubMedCrossRef Griepp RB, Di Luozzo G: Hypothermia for aortic surgery. J Thorac Cardiovasc Surg. 2013, 145 (3, Supplement): S56-S58. 10.1016/j.jtcvs.2012.11.072.PubMedCrossRef
17.
go back to reference de Lange F, Dieleman JM, Jungwirth B, Kalkman CJ: Effects of cardiopulmonary bypass on neurocognitive performance and cytokine release in old and diabetic rats. Br J Anaesth. 2007, 99 (2): 177-183. 10.1093/bja/aem116.PubMedCrossRef de Lange F, Dieleman JM, Jungwirth B, Kalkman CJ: Effects of cardiopulmonary bypass on neurocognitive performance and cytokine release in old and diabetic rats. Br J Anaesth. 2007, 99 (2): 177-183. 10.1093/bja/aem116.PubMedCrossRef
18.
go back to reference Toledo-Pereyra LH, Lopez-Neblina F, Toledo AH: Protein Kinases in Organ Ischemia and Reperfusion: Journal of Investigative Surgery. J Invest Surg. 2008, 21 (4): 215-226. 10.1080/08941930802130149.PubMedCrossRef Toledo-Pereyra LH, Lopez-Neblina F, Toledo AH: Protein Kinases in Organ Ischemia and Reperfusion: Journal of Investigative Surgery. J Invest Surg. 2008, 21 (4): 215-226. 10.1080/08941930802130149.PubMedCrossRef
19.
go back to reference Cuschieri J, Maier RV: Mitogen-activated protein kinase (MAPK). Crit Care Med. 2005, 33 (12 Suppl): S417-S419. 10.1097/01.CCM.0000191714.39495.A6.PubMedCrossRef Cuschieri J, Maier RV: Mitogen-activated protein kinase (MAPK). Crit Care Med. 2005, 33 (12 Suppl): S417-S419. 10.1097/01.CCM.0000191714.39495.A6.PubMedCrossRef
20.
go back to reference Lakkisto P, Csonka C, Fodor G, Bencsik P, Voipio-Pulkki LM, Ferdinandy P, Pulkki K: The heme oxygenase inducer hemin protects against cardiac dysfunction and ventricular fibrillation in ischaemic/reperfused rat hearts: role of connexin 43. Scand J Clin Lab Invest. 2009, 69 (2): 209-218. 10.1080/00365510802474392.PubMedCrossRef Lakkisto P, Csonka C, Fodor G, Bencsik P, Voipio-Pulkki LM, Ferdinandy P, Pulkki K: The heme oxygenase inducer hemin protects against cardiac dysfunction and ventricular fibrillation in ischaemic/reperfused rat hearts: role of connexin 43. Scand J Clin Lab Invest. 2009, 69 (2): 209-218. 10.1080/00365510802474392.PubMedCrossRef
21.
go back to reference Boengler K, Hilfiker-Kleiner D, Drexler H, Heusch G, Schulz R: The myocardial JAK/STAT pathway: from protection to failure. Pharmacol Ther. 2008, 120 (2): 172-185. 10.1016/j.pharmthera.2008.08.002.PubMedCrossRef Boengler K, Hilfiker-Kleiner D, Drexler H, Heusch G, Schulz R: The myocardial JAK/STAT pathway: from protection to failure. Pharmacol Ther. 2008, 120 (2): 172-185. 10.1016/j.pharmthera.2008.08.002.PubMedCrossRef
22.
go back to reference Pinto A, Juniper DT, Sanil M, Morgan L, Clark L, Sies H, Rayman MP, Steinbrenner H: Supranutritional selenium induces alterations in molecular targets related to energy metabolism in skeletal muscle and visceral adipose tissue of pigs. J Inorg Biochem. 2012, 114: 47-54. 10.1016/j.jinorgbio.2012.04.011.PubMedCrossRef Pinto A, Juniper DT, Sanil M, Morgan L, Clark L, Sies H, Rayman MP, Steinbrenner H: Supranutritional selenium induces alterations in molecular targets related to energy metabolism in skeletal muscle and visceral adipose tissue of pigs. J Inorg Biochem. 2012, 114: 47-54. 10.1016/j.jinorgbio.2012.04.011.PubMedCrossRef
23.
go back to reference Heinen NM, Putz VE, Gorgens JI, Huhn R, Gruber Y, Barthuber C, Preckel B, Pannen BH, Bauer I: Cardioprotection by remote ischemic preconditioning exhibits a signaling pattern different from local ischemic preconditioning. Shock (Augusta, Ga). 2011, 36 (1): 45-53. 10.1097/SHK.0b013e31821d8e77.CrossRef Heinen NM, Putz VE, Gorgens JI, Huhn R, Gruber Y, Barthuber C, Preckel B, Pannen BH, Bauer I: Cardioprotection by remote ischemic preconditioning exhibits a signaling pattern different from local ischemic preconditioning. Shock (Augusta, Ga). 2011, 36 (1): 45-53. 10.1097/SHK.0b013e31821d8e77.CrossRef
24.
go back to reference Bell JR, Eaton P, Shattock MJ: Role of p38-mitogen-activated protein kinase in ischaemic preconditioning in rat heart. Clin Exp Pharmacol Physiol. 2008, 35 (2): 126-134.PubMed Bell JR, Eaton P, Shattock MJ: Role of p38-mitogen-activated protein kinase in ischaemic preconditioning in rat heart. Clin Exp Pharmacol Physiol. 2008, 35 (2): 126-134.PubMed
25.
go back to reference Wolf PS, Merry HE, Farivar AS, McCourtie AS, Mulligan MS: Stress-activated protein kinase inhibition to ameliorate lung ischemia reperfusion injury. J Thorac Cardiovasc Surg. 2008, 135 (3): 656-665. 10.1016/j.jtcvs.2007.11.026.PubMedCrossRef Wolf PS, Merry HE, Farivar AS, McCourtie AS, Mulligan MS: Stress-activated protein kinase inhibition to ameliorate lung ischemia reperfusion injury. J Thorac Cardiovasc Surg. 2008, 135 (3): 656-665. 10.1016/j.jtcvs.2007.11.026.PubMedCrossRef
26.
go back to reference Friedman M, Sellke FW, Wang SY, Weintraub RM, Johnson RG: Parameters of pulmonary injury after total or partial cardiopulmonary bypass. Circulation. 1994, 90 (5 Pt 2): II262-II268.PubMed Friedman M, Sellke FW, Wang SY, Weintraub RM, Johnson RG: Parameters of pulmonary injury after total or partial cardiopulmonary bypass. Circulation. 1994, 90 (5 Pt 2): II262-II268.PubMed
27.
go back to reference King LA, Toledo AH, Rivera-Chavez FA, Toledo-Pereyra LH: Role of p38 and JNK in liver ischemia and reperfusion. J Hepatobiliary Pancreat Surg. 2009, 16 (6): 763-770. 10.1007/s00534-009-0155-x.PubMedCrossRef King LA, Toledo AH, Rivera-Chavez FA, Toledo-Pereyra LH: Role of p38 and JNK in liver ischemia and reperfusion. J Hepatobiliary Pancreat Surg. 2009, 16 (6): 763-770. 10.1007/s00534-009-0155-x.PubMedCrossRef
28.
go back to reference Ferenbach DA, Kluth DC, Hughes J: Hemeoxygenase-1 and renal ischaemia-reperfusion injury. Nephron Exp Nephrol. 2010, 115 (3): e33-e37. 10.1159/000313828.PubMedCrossRef Ferenbach DA, Kluth DC, Hughes J: Hemeoxygenase-1 and renal ischaemia-reperfusion injury. Nephron Exp Nephrol. 2010, 115 (3): e33-e37. 10.1159/000313828.PubMedCrossRef
29.
go back to reference Chen YT, Tsai TH, Yang CC, Sun CK, Chang LT, Chen HH, Chang CL, Sung PH, Zhen YY, Leu S, Chang HW, Chen YL, Yip HK: Exendin-4 and sitagliptin protect kidney from ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction. J Transl Med. 2013, 11 (1): 270-10.1186/1479-5876-11-270.PubMedPubMedCentralCrossRef Chen YT, Tsai TH, Yang CC, Sun CK, Chang LT, Chen HH, Chang CL, Sung PH, Zhen YY, Leu S, Chang HW, Chen YL, Yip HK: Exendin-4 and sitagliptin protect kidney from ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction. J Transl Med. 2013, 11 (1): 270-10.1186/1479-5876-11-270.PubMedPubMedCentralCrossRef
30.
go back to reference Wang Z, Liu Y, Han Y, Guan W, Kou X, Fu J, Yang D, Ren H, He D, Zhou L, Zeng C: Protective effects of aliskiren on ischemia-reperfusion-induced renal injury in rats. Eur J Pharmacol. 2013, 89: 115- Wang Z, Liu Y, Han Y, Guan W, Kou X, Fu J, Yang D, Ren H, He D, Zhou L, Zeng C: Protective effects of aliskiren on ischemia-reperfusion-induced renal injury in rats. Eur J Pharmacol. 2013, 89: 115-
31.
go back to reference Khabar KSA, Elbarbary MA, Khouqeer F, Devol E, Al-Gain S, Al-Halees Z: Circulating Endotoxin and Cytokines after Cardiopulmonary Bypass: Differential Correlation with Duration of Bypass and Systemic Inflammatory Response/Multiple Organ Dysfunction Syndromes. Clin Immunol Immunopathol. 1997, 85 (1): 97-103. 10.1006/clin.1997.4413.PubMedCrossRef Khabar KSA, Elbarbary MA, Khouqeer F, Devol E, Al-Gain S, Al-Halees Z: Circulating Endotoxin and Cytokines after Cardiopulmonary Bypass: Differential Correlation with Duration of Bypass and Systemic Inflammatory Response/Multiple Organ Dysfunction Syndromes. Clin Immunol Immunopathol. 1997, 85 (1): 97-103. 10.1006/clin.1997.4413.PubMedCrossRef
32.
go back to reference Aouifi A, Piriou V, Blanc P, Bouvier H, Bastien O, Chiari P, Rousson R, Evans R, Lehot JJ: Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations. Br J Anaesth. 1999, 83 (4): 602-607. 10.1093/bja/83.4.602.PubMedCrossRef Aouifi A, Piriou V, Blanc P, Bouvier H, Bastien O, Chiari P, Rousson R, Evans R, Lehot JJ: Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations. Br J Anaesth. 1999, 83 (4): 602-607. 10.1093/bja/83.4.602.PubMedCrossRef
33.
go back to reference da Silva R, Grampp T, Pasch T, Schaub MC, Zaugg M: Differential Activation of Mitogen-activated Protein Kinases in Ischemic and Anesthetic Preconditioning. Anesthesiology. 2004, 100 (1): 59-69. 10.1097/00000542-200401000-00013.PubMedCrossRef da Silva R, Grampp T, Pasch T, Schaub MC, Zaugg M: Differential Activation of Mitogen-activated Protein Kinases in Ischemic and Anesthetic Preconditioning. Anesthesiology. 2004, 100 (1): 59-69. 10.1097/00000542-200401000-00013.PubMedCrossRef
34.
go back to reference Xu YF, Liu M, Peng B, Che JP, Zhang HM, Yan Y, Wang GC, Wu YC, Zheng JH: Protective effects of SP600125 on renal ischemia-reperfusion injury in rats. J Surg Res. 2011, 169 (1): e77-e84. 10.1016/j.jss.2011.02.021.PubMedCrossRef Xu YF, Liu M, Peng B, Che JP, Zhang HM, Yan Y, Wang GC, Wu YC, Zheng JH: Protective effects of SP600125 on renal ischemia-reperfusion injury in rats. J Surg Res. 2011, 169 (1): e77-e84. 10.1016/j.jss.2011.02.021.PubMedCrossRef
Metadata
Title
A cardiopulmonary bypass with deep hypothermic circulatory arrest rat model for the investigation of the systemic inflammation response and induced organ damage
Authors
Melanie Engels
Esra Bilgic
Antonio Pinto
Edwin Vasquez
Lena Wollschläger
Holger Steinbrenner
Kristine Kellermann
Payam Akhyari
Artur Lichtenberg
Udo Boeken
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Inflammation / Issue 1/2014
Electronic ISSN: 1476-9255
DOI
https://doi.org/10.1186/s12950-014-0026-3

Other articles of this Issue 1/2014

Journal of Inflammation 1/2014 Go to the issue